MAAT PHARMA | Finanzwire

Basculer en Français

10169	Companies
209109	Keywords
139213	Articles
110847	Press releases

Home
Companies
MAAT PHARMA

PRESS RELEASE

published on 11/19/2025 at 11:11, 4 months 18 days ago

Original-Research: MaaT Pharma SACA (von First Berlin Equity Research GmbH): BUY
First Berlin Equity Research updates BUY recommendation for MaaT Pharma SACA, citing successful €9.1m capital raise with strong investor support for lead drug Xervyteg. Company well-positioned for commercialization

First Berlin Equity Research Capital Increase Investment Advice Xervyteg MaaT Pharma SACA
BRIEF

published on 11/14/2025 at 23:10, 4 months 23 days ago

MaaT Pharma: successful fundraising of 9.1 million euros

Investors Biotechnology Fundraising Microbiome Medical Innovation
PRESS RELEASE

published on 11/14/2025 at 23:05, 4 months 23 days ago

Inside Information / Operations of the issuer (acquisitions, sales...)
MaaT Pharma successfully completes Global Offering of €9.1 million, strengthening financial position and supporting development of Microbiome Therapies for cancer patients

Financial Position Global Offering MaaT Pharma Cancer Patients Microbiome Therapies
BRIEF

published on 11/13/2025 at 19:45, 4 months 24 days ago

MaaT Pharma launches a capital increase

Capital Increase Qualified Investors MaaT Pharma Global Offer Xervyteg® Marketing
PRESS RELEASE

published on 11/13/2025 at 19:40, 4 months 24 days ago

Inside Information / Other news releases
MaaT Pharma launches a capital increase of approximately €9 million through a private placement and PrimaryBid offering. Funds raised to support Xervyteg® commercialization and extend cash runway until summer 2026

Private Placement Investment Capital Increase MaaT Pharma Xervyteg
BRIEF

published on 11/05/2025 at 07:35, 5 months 3 days ago

MaaT Pharma Reveals Promising Preclinical Data for MaaT034

Cancer Treatment Immunotherapy MaaT Pharma Microbiome Therapy MaaT034
PRESS RELEASE

published on 11/05/2025 at 07:30, 5 months 3 days ago

Inside Information / Other news releases
MaaT Pharma presents updated preclinical data for MaaT034, showing immune activation and anti-tumor activity at SITC Annual Meeting. New findings enhance patient responses to immunotherapy

Preclinical Data MaaT Pharma SITC Annual Meeting Immune Activation Anti-tumor Activity
BRIEF

published on 11/04/2025 at 11:43, 5 months 3 days ago

MaaT Pharma Receives BUY Rating from First Berlin Equity Research

Biotechnology Clinical Trials Investment Cancer Treatment Microbiome Therapy
PRESS RELEASE

published on 11/04/2025 at 11:38, 5 months 3 days ago

Original-Research: MaaT Pharma SACA (von First Berlin Equity Research GmbH): BUY
First Berlin Equity Research initiates coverage on MaaT Pharma SACA with a BUY rating and EUR 17 price target. MaaT Pharma focuses on microbiome-based therapies for oncology, with high clinical impact and late-stage pipeline

Oncology BUY Rating Clinical-stage Biotechnology MaaT Pharma SACA Microbiome-based Therapies
BRIEF

published on 11/04/2025 at 07:35, 5 months 4 days ago

MaaT Pharma Third Quarter 2025 Financial Results and Financing Update

Financial Results MaaT Pharma European Medicines Agency Xervyteg® Clinigen Partnership

Accesswire

Published on 04/08/2026 at 08:05, 1 hour 28 minutes ago

Tocvan Announces Addition of Second Drill Rig and Accelerates High-Priority Drill Targets at Flagship Gran Pilar Gold-Silver Project
Published on 04/08/2026 at 02:50, 6 hours 43 minutes ago

Panther Minerals Announces Appointment of Rick Mah to Board of Directors
Published on 04/08/2026 at 01:35, 7 hours 58 minutes ago

Polaris Renewable Energy Announces Q1 2026 Investor Call Details
Published on 04/08/2026 at 00:40, 8 hours 53 minutes ago

Relevant Gold Announces Initial Closing of Strategic Financing
Published on 04/08/2026 at 00:10, 9 hours 23 minutes ago

Trans Canada Gold Completes the Acquisition of the Harrison Lake District Scale Gold Property and First Tranche of the Non-Brokered Private Placement

View all ACCESSWIRE

EQS Group

Published on 04/08/2026 at 09:23, 9 minutes ago

IBU-tec advanced materials AG: 2025 annual financial statements presented and dividend proposal of EUR 0.12 per share
Published on 04/08/2026 at 09:10, 22 minutes ago

Reolink Announces Official Integration with Homey to Elevate Smart Home Automation
Published on 04/08/2026 at 09:05, 28 minutes ago

Lenzing Commissions 14 MW Power‑to‑Heat Facility, Strengthening Grid Stability and Heat Management
Published on 04/08/2026 at 09:00, 32 minutes ago

Original-Research: EPH Group AG (von NuWays AG): BUY
Published on 04/08/2026 at 09:00, 32 minutes ago

Original-Research: ASMALLWORLD AG (von NuWays AG): BUY

Les Echos

Published on 04/08/2026 at 08:30, 1 hour 3 minutes ago

Edenred Mobility and Electra form a strategic partnership to accelerate the electrification of commercial fleets in France
Published on 04/07/2026 at 17:57, 15 hours 35 minutes ago

Peugeot Invest publishes its 2025 Universal Registration Document
Published on 04/07/2026 at 17:45, 15 hours 48 minutes ago

ENGIE accelerates the deployment of battery storage with nearly 400 MW of new projects in Europe
Published on 04/07/2026 at 17:45, 15 hours 48 minutes ago

Weekly share buyback
Published on 04/07/2026 at 17:38, 15 hours 54 minutes ago

Reporting on share buyback transactions carried out between March 30 and April 2, 2026

View all LES ECHOS COMFI WIRE